Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Hospital Practice (Office Ed.)|September 30, 1987
Evaluation and treatment of testicular cancerP J HeskethSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1994
Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonistsP J HeskethSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2001
Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomitingP J HeskethCancer Investigation|March 8, 2000
Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomitingP J HeskethThe Oncologist|July 8, 1999
Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practiceP J HeskethSeminars in Oncology|August 1, 1992
Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesisP J HeskethThe New England Journal of Medicine|December 9, 1993
Control of chemotherapy-induced emesisS M Grunberg, P J HeskethDrugs in R&D|February 5, 2000
Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in developmentA N Rizk, P J HeskethSeminars in Oncology|December 1, 1992
Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy resultsJ D Hainsworth, P J HeskethPageof 6